Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Cuiper LL et al. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. 1996 J. Appl. Physiol. pmid:8847301
Nowak J et al. Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. 1996 Clin Physiol pmid:8842572
Stichtenoth DO et al. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. 1995 Nov-Dec Prostaglandins pmid:8838242
Muller M and Sorrell TC Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. 1995 Nov-Dec Prostaglandins pmid:8838240
Fylling AC et al. Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. 1995 Nov-Dec Prostaglandins pmid:8838239
Meade CJ et al. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs. 1996 Jpn. J. Pharmacol. pmid:8835638
Osiovich H et al. Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. 1995 Biol. Neonate pmid:8835089
Myers SI et al. Long-term resuscitation of hemorrhage/reperfusion injury (H/R) stimulates renal PGE2 release. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8832762
Mizugaki M et al. Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard. 1995 Rapid Commun. Mass Spectrom. pmid:8829485
Ishibashi M et al. Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds. 1995 Rapid Commun. Mass Spectrom. pmid:8829476
Mitten LA et al. Phenylbutazone increases right atrial pressure and heart rate of running horses. 1996 J. Appl. Physiol. pmid:8828679
Watanabe M et al. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome]. 1996 Nihon Jinzo Gakkai Shi pmid:8828355
Meenan J et al. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. 1996 Eur J Gastroenterol Hepatol pmid:8823572
Wagner RS et al. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. 1996 Shock pmid:8821102
Davì G et al. Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. 1996 Thromb. Haemost. pmid:8819248
Galbraith EA and McKellar QA Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. 1996 Res. Vet. Sci. pmid:8819199
Landoni MF et al. Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. 1996 Res. Vet. Sci. pmid:8819190
Yoshida SH et al. Dietary Juniperis virginiensis seed oil decreased pentobarbital-associated mortalities among DBA/1 mice treated with collagen-adjuvant emulsions. 1996 J Lipid Mediat Cell Signal pmid:8816989
Pace-Asciak CR et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. 1996 Clin. Chim. Acta pmid:8814965
Zhen ZY et al. Experimental study on microthrombi and myocardial injuries. 1996 Microvasc. Res. pmid:8812763
Giulian D et al. Activated microglia are the principal glial source of thromboxane in the central nervous system. 1996 Neurochem. Int. pmid:8808790
González ET et al. Prostanoid modulation of glucose transport in isolated diabetic rat uterus. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804128
Feng J et al. Beneficial effects of iloprost cardioplegia in ischemic arrest in isolated working rat heart. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804125
Fekkes D et al. Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804122
Lewy RI et al. Intravenous heparin initiates in-vivo synthesis and release of thromboxane in angina pectoris. 1979 Lancet pmid:87990
Morrow JD et al. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. 1996 J. Biol. Chem. pmid:8798513
Fox GA et al. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. 1996 J. Cardiovasc. Pharmacol. pmid:8797133
Sakurai S et al. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities. 1996 Chem. Pharm. Bull. pmid:8795270
Ko FN et al. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. 1996 J. Pharm. Pharmacol. pmid:8794990
Uematsu T et al. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. 1996 J. Pharm. Pharmacol. pmid:8794987
Eriksson M et al. Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. 1996 Acta Anaesthesiol Scand pmid:8792882
Collins CE et al. Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 1996 Aliment. Pharmacol. Ther. pmid:8791957
Aïssa J et al. Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist. 1996 Eur. J. Pharmacol. pmid:8791000
Vaskonen T et al. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. 1996 Blood Press. pmid:8790929
Raptopoulos D et al. The effect of xylazine on plasma thromboxane B2 concentration in sheep. 1995 J. Vet. Pharmacol. Ther. pmid:8789696
Bell SJ et al. Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection. 1996 Jan-Feb JPEN J Parenter Enteral Nutr pmid:8788262
Zheng NX et al. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits. 1995 Biol. Pharm. Bull. pmid:8787798
Cuzzolin L et al. Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in rats. 1996 Life Sci. pmid:8786689
Uhlig S et al. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. 1996 Mol. Med. pmid:8784790
Gennaro M et al. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. 1996 Cardiovasc Surg pmid:8782946
Nabe T et al. Sephadex G-200-induced eosinophil infiltration into airways in non-sensitized and sensitized guinea pigs, and responsiveness of the cells to stimuli in vitro. 1996 Jpn. J. Pharmacol. pmid:8774762
Quoc KP and Pascaud M Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. 1996 Ann. Nutr. Metab. pmid:8773734
Madan ZM and Sainani GS Effect of aspirin treatment on plasma levels of keto PGF 1 alpha and thromboxane B2. 1995 J Assoc Physicians India pmid:8773058
Mehta PJ et al. More uses of known drugs. 1995 J Assoc Physicians India pmid:8773057
Closa D et al. Hepatic involvement in pancreatitis-induced lung damage. 1996 Am. J. Physiol. pmid:8772495
Abernathy VJ et al. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. 1996 Am. J. Physiol. pmid:8770090
Shirabe K et al. Inhibition of thromboxane A2 activity during warm ischemia of the liver. 1996 J. Surg. Res. pmid:8769950
Qiu BS et al. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. 1996 Dig. Dis. Sci. pmid:8769290
Hrboticky N et al. Linoleic acid esterified in low density lipoprotein serves as substrate for increased arachidonic acid synthesis in differentiating monocytic cells. 1996 Biochim. Biophys. Acta pmid:8765140
Fleisch JH et al. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. 1996 J. Pharmacol. Exp. Ther. pmid:8764358
Izaki S et al. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. 1996 Br. J. Dermatol. pmid:8763425
Fuse I et al. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency. 1996 Int. J. Hematol. pmid:8762815
Kuroiwa M et al. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. 1996 Int. J. Hematol. pmid:8762814
Xiao J et al. [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. 1995 Zhonghua Wai Ke Za Zhi pmid:8762548
Zhang M et al. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril]. 1995 Sheng Li Xue Bao pmid:8762446
Yan GT et al. [Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation]. 1995 Sheng Li Xue Bao pmid:8762444
Fimognari FL et al. Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. 1996 J. Lab. Clin. Med. pmid:8759943
Hibi S et al. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase. 1996 J. Med. Chem. pmid:8759636
Janabi N et al. Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways. 1996 J. Immunol. pmid:8757337
Mito Y [Thromboxane B2 (TXB2)]. 1995 Nippon Rinsho pmid:8753342
Gu YJ et al. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. 1996 J. Thorac. Cardiovasc. Surg. pmid:8751518
Yokoyama I et al. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. 1996 Transpl. Int. pmid:8748415
Mathie RT et al. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog. 1995 Perfusion pmid:8747897
Yoshida T et al. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. 1996 Lupus pmid:8743126
Yang JM et al. Sodium nonivamide acetate: a non-pungently antinociceptive capsaicin derivative with unusual anti-inflammatory properties. 1996 Gen. Pharmacol. pmid:8742512
Laffi G et al. Defective aggregation in cirrhosis is independent of in vivo platelet activation. 1996 J. Hepatol. pmid:8738730
Young JM et al. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. 1996 Inflamm. Res. pmid:8737748
Ravn HB et al. Magnesium inhibits human platelets. 1996 Blood Coagul. Fibrinolysis pmid:8735829
Lechi C et al. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid. 1996 Blood Coagul. Fibrinolysis pmid:8735820
Jancinová V et al. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. 1996 Blood Coagul. Fibrinolysis pmid:8735816
Cheng Z et al. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey. 1996 J. Vet. Pharmacol. Ther. pmid:8735424
Li H [Research on plasma TXA2, PGI2 levels, blood stasis syndrome and promoting blood circulation]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732157
Liang-min LD et al. [Effect of age on hemostasis and plasma level of TXB2 and 6-keto-PGF1 alpha]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732148
Liang XC et al. [Study on relationship of lipid peroxide in coronary heart disease with and without diabetes]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732128
Xiong YL and Zhao HY Experimental studies on preventive effects of API0134 on vessel reocclusion after thrombolysis. 1995 J. Tongji Med. Univ. pmid:8731957
Xiong YL and Zhao HY Effect of captopril on antithrombus function of endothelium. 1995 J. Tongji Med. Univ. pmid:8731927
Isozaki H et al. Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. 1996 Surg. Today pmid:8727944
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Yanase T et al. Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. 1996 Shock pmid:8721389
Kruse-Elliott KT et al. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. 1996 Shock pmid:8721386
Oláh L et al. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. 1996 Orv Hetil pmid:8714038
Tishler M et al. Salivary eicosanoid concentration in patients with Sjögren's syndrome. 1996 Ann. Rheum. Dis. pmid:8712887
Herrick AL et al. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. 1996 Ann. Rheum. Dis. pmid:8712862
Howarth SR et al. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. 1995 Placenta pmid:8710799
Liu H et al. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697924
Sun B et al. [The experimental observation on the procedure of atherosclerotic restenosis following PTCA]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697911
Nosál R et al. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro. 1996 Inflamm. Res. pmid:8696916
Jensen N et al. Recovery of endothelial cells and prostanoid production in endothelial cell-seeded grafts. 1996 Eur J Vasc Endovasc Surg pmid:8696898
Takase B et al. Arachidonic acid metabolites in acute myocardial infarction. 1996 Angiology pmid:8686958
Malý J et al. Migraine--a haematological disorder? 1995 Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove pmid:8685625
Taylor PM et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. 1996 Res. Vet. Sci. pmid:8685536
Cervar M et al. Altered release of endothelin-1,2 and thromboxane B2 from trophoblastic cells in pre-eclampsia. 1996 Eur. J. Clin. Invest. pmid:8682152
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Myers SI et al. Regulation of eicosanoid synthesis in fibroblasts from inflamed gallbladders. 1995 Mol. Cell. Endocrinol. pmid:8674862
Stein CM et al. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. 1996 Arthritis Rheum. pmid:8670323
Saitta A et al. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test. 1995 Jul-Aug Pharmacol. Res. pmid:8668647
Haimovich B et al. The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets. 1996 J. Biol. Chem. pmid:8663117
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Dehmlow C et al. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. 1996 Life Sci. pmid:8649189